Which has better earnings & valuation, ADUS or HNGE?

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.54 $95.91M $5.70 20.54 Hinge Health $587.86M 13.05 -$528.26M $1.28 74.31

Does the media prefer ADUS or HNGE?

In the previous week, Hinge Health had 3 more articles in the media than Addus HomeCare. MarketBeat recorded 13 mentions for Hinge Health and 10 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.70 beat Hinge Health's score of 0.29 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, CHE or ADUS?

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.53B 2.60 $265.24M $19.91 25.27 Addus HomeCare $1.42B 1.54 $95.91M $5.70 20.54

Is CHE or ADUS more profitable?

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.60% 31.77% 18.90% Addus HomeCare 7.13% 9.96% 7.62%

Does the media favor CHE or ADUS?

In the previous week, Addus HomeCare had 4 more articles in the media than Chemed. MarketBeat recorded 10 mentions for Addus HomeCare and 6 mentions for Chemed. Chemed's average media sentiment score of 0.79 beat Addus HomeCare's score of 0.70 indicating that Chemed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Addus HomeCare 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HIMS or ADUS?

In the previous week, Hims & Hers Health had 42 more articles in the media than Addus HomeCare. MarketBeat recorded 52 mentions for Hims & Hers Health and 10 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.70 beat Hims & Hers Health's score of 0.12 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 8 Very Positive mention(s) 4 Positive mention(s) 35 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Addus HomeCare 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Is RDNT or ADUS more profitable?

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.93% 2.61% 0.91% Addus HomeCare 7.13% 9.96% 7.62%

Does the media favor RDNT or ADUS?

In the previous week, Addus HomeCare had 5 more articles in the media than RadNet. MarketBeat recorded 10 mentions for Addus HomeCare and 5 mentions for RadNet. Addus HomeCare's average media sentiment score of 0.70 beat RadNet's score of 0.50 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Addus HomeCare 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ADUS or LFST?

In the previous week, Addus HomeCare had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for Addus HomeCare and 4 mentions for LifeStance Health Group. Addus HomeCare's average media sentiment score of 0.70 beat LifeStance Health Group's score of 0.59 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Addus HomeCare (ADUS) Competitors

$117.07 -0.99 (-0.84%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$117.08 +0.02 (+0.01%)

As of 09/18/2026 07:30 PM Eastern

Compare

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Addus HomeCare stock or one of its competitors? Addus HomeCare's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Addus HomeCare compare to Hinge Health?

Addus HomeCare (NASDAQ:ADUS) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

In the previous week, Hinge Health had 3 more articles in the media than Addus HomeCare. MarketBeat recorded 13 mentions for Hinge Health and 10 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.70 beat Hinge Health's score of 0.29 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Addus HomeCare has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market.

Addus HomeCare presently has a consensus price target of $128.00, suggesting a potential upside of 9.34%. Hinge Health has a consensus price target of $101.93, suggesting a potential upside of 7.17%. Given Addus HomeCare's higher possible upside, research analysts plainly believe Addus HomeCare is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

Hinge Health has a net margin of 15.15% compared to Addus HomeCare's net margin of 7.13%. Hinge Health's return on equity of 51.60% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Hinge Health	15.15%	51.60%	14.16%

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.54	$95.91M	$5.70	20.54
Hinge Health	$587.86M	13.05	-$528.26M	$1.28	74.31

Summary

Hinge Health beats Addus HomeCare on 10 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Chemed?

Chemed (NYSE:CHE) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.60	$265.24M	$19.91	25.27
Addus HomeCare	$1.42B	1.54	$95.91M	$5.70	20.54

Chemed presently has a consensus target price of $530.75, indicating a potential upside of 5.49%. Addus HomeCare has a consensus target price of $128.00, indicating a potential upside of 9.34%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

In the previous week, Addus HomeCare had 4 more articles in the media than Chemed. MarketBeat recorded 10 mentions for Addus HomeCare and 6 mentions for Chemed. Chemed's average media sentiment score of 0.79 beat Addus HomeCare's score of 0.70 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Addus HomeCare	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.9% of Chemed shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 3.3% of Chemed shares are held by company insiders. Comparatively, 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Chemed has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Addus HomeCare	7.13%	9.96%	7.62%

Summary

Chemed beats Addus HomeCare on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Addus HomeCare has a net margin of 7.13% compared to Hims & Hers Health's net margin of -5.51%. Addus HomeCare's return on equity of 9.96% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Addus HomeCare	7.13%	9.96%	7.62%

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.78	$128.37M	-$0.63	N/A
Addus HomeCare	$1.42B	1.54	$95.91M	$5.70	20.54

In the previous week, Hims & Hers Health had 42 more articles in the media than Addus HomeCare. MarketBeat recorded 52 mentions for Hims & Hers Health and 10 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.70 beat Hims & Hers Health's score of 0.12 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	8 Very Positive mention(s)	4 Positive mention(s)	35 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Addus HomeCare	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Hims & Hers Health has a beta of 2.42, suggesting that its share price is 142% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Hims & Hers Health currently has a consensus price target of $32.43, indicating a potential upside of 15.82%. Addus HomeCare has a consensus price target of $128.00, indicating a potential upside of 9.34%. Given Hims & Hers Health's higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Summary

Addus HomeCare beats Hims & Hers Health on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to RadNet?

RadNet (NASDAQ:RDNT) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Addus HomeCare had 5 more articles in the media than RadNet. MarketBeat recorded 10 mentions for Addus HomeCare and 5 mentions for RadNet. Addus HomeCare's average media sentiment score of 0.70 beat RadNet's score of 0.50 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Addus HomeCare	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Addus HomeCare has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.93	-$18.65M	-$0.27	N/A
Addus HomeCare	$1.42B	1.54	$95.91M	$5.70	20.54

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 18.42%. Addus HomeCare has a consensus price target of $128.00, suggesting a potential upside of 9.34%. Given RadNet's stronger consensus rating and higher probable upside, equities research analysts plainly believe RadNet is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Addus HomeCare	7.13%	9.96%	7.62%

Summary

Addus HomeCare beats RadNet on 9 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to LifeStance Health Group?

Addus HomeCare (NASDAQ:ADUS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Addus HomeCare has a net margin of 7.13% compared to LifeStance Health Group's net margin of 3.19%. Addus HomeCare's return on equity of 9.96% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
LifeStance Health Group	3.19%	3.39%	2.33%

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Addus HomeCare presently has a consensus price target of $128.00, suggesting a potential upside of 9.34%. LifeStance Health Group has a consensus price target of $12.88, suggesting a potential upside of 2.43%. Given Addus HomeCare's higher possible upside, analysts plainly believe Addus HomeCare is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Addus HomeCare had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for Addus HomeCare and 4 mentions for LifeStance Health Group. Addus HomeCare's average media sentiment score of 0.70 beat LifeStance Health Group's score of 0.59 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Addus HomeCare has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

Addus HomeCare has higher earnings, but lower revenue than LifeStance Health Group. Addus HomeCare is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.54	$95.91M	$5.70	20.54
LifeStance Health Group	$1.42B	3.37	$9.66M	$0.13	96.69

Summary

Addus HomeCare beats LifeStance Health Group on 10 of the 16 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.20B	$9.80B	$7.26B	$13.14B
Dividend Yield	N/A	2.61%	2.57%	12.30%
P/E Ratio	20.54	34.09	274.66	25.40
Price / Sales	1.54	4.98	693.95	114.69
Price / Cash	18.18	123.23	77.42	51.66
Price / Book	1.99	5.30	10.46	6.33
Net Income	$95.91M	$313.45M	$3.49B	$358.33M
7 Day Performance	-0.02%	1.65%	0.59%	1.11%
1 Month Performance	-2.46%	-0.98%	-2.02%	-2.67%
1 Year Performance	4.62%	15.82%	18.09%	6.01%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	4.0364 of 5 stars	$117.07 -0.8%	$128.00 +9.3%	+6.6%	$2.20B	$1.42B	20.54	50,659	High Trading Volume
HNGE Hinge Health	3.1219 of 5 stars	$92.30 -0.1%	$101.93 +10.4%	+67.2%	$7.45B	$587.86M	72.11	1,437	Insider Trade
CHE Chemed	4.2585 of 5 stars	$521.21 +0.3%	$530.75 +1.8%	+9.8%	$6.77B	$2.53B	26.02	15,811	Analyst Downgrade
HIMS Hims & Hers Health	2.5999 of 5 stars	$28.03 +1.2%	$32.50 +15.9%	-50.1%	$6.54B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Up
RDNT RadNet	2.9443 of 5 stars	$73.11 -0.8%	$90.00 +23.1%	-0.8%	$5.75B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 9/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Addus HomeCare compare to Hinge Health?

Summary

How does Addus HomeCare compare to Chemed?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to RadNet?

Summary

How does Addus HomeCare compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Addus HomeCare compare to Hinge Health?

Does the media prefer ADUS or HNGE?

Do institutionals and insiders hold more shares of ADUS or HNGE?

Which has more risk and volatility, ADUS or HNGE?

Do analysts rate ADUS or HNGE?

Is ADUS or HNGE more profitable?

Which has better earnings & valuation, ADUS or HNGE?

Summary

How does Addus HomeCare compare to Chemed?

Which has preferable earnings and valuation, CHE or ADUS?

Do analysts prefer CHE or ADUS?

Does the media favor CHE or ADUS?

Do insiders & institutionals have more ownership in CHE or ADUS?

Which has more risk and volatility, CHE or ADUS?

Is CHE or ADUS more profitable?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Is HIMS or ADUS more profitable?

Which has higher valuation & earnings, HIMS or ADUS?

Does the media favor HIMS or ADUS?

Do insiders & institutionals have more ownership in HIMS or ADUS?

Which has more risk and volatility, HIMS or ADUS?

Do analysts prefer HIMS or ADUS?

Summary

How does Addus HomeCare compare to RadNet?

Does the media favor RDNT or ADUS?

Do institutionals & insiders hold more shares of RDNT or ADUS?

Which has stronger earnings and valuation, RDNT or ADUS?

Which has more volatility and risk, RDNT or ADUS?

Do analysts recommend RDNT or ADUS?

Is RDNT or ADUS more profitable?

Summary

How does Addus HomeCare compare to LifeStance Health Group?

Is ADUS or LFST more profitable?

Do insiders and institutionals hold more shares of ADUS or LFST?

Do analysts recommend ADUS or LFST?

Does the media refer more to ADUS or LFST?

Which has more risk and volatility, ADUS or LFST?

Which has higher earnings & valuation, ADUS or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools